白云区企业家大会在华为广州研发中心召开。谭札烽 摄 1月4日，广州市白云区企业家大会在华为广州研发中心召开。大会以"奋进'十五五'实现新突破"为主 题，推动企业发展战略与白云区"十五五"规划深度融合，努力构建"双赢、多赢、共赢"发展格局。超过 160位各行业领域企业家参加大会。 在这当中，既有龙头企业、上市公司，也汇聚了一批高新技术企业、"专精特新"小巨人企业为代表的创 新力量。企业家代表们一致认为，白云区区位优势明显、产业基础扎实、政策支持有力，特别是 在"6+6+X"现代产业集群培育和营商环境优化方面的持续发力，为企业成长提供了广阔的舞台。 作为深耕白云的央企龙头，南方航空正全力发挥航空主业优势，为白云区的现代化产业体系，装上强劲 的"航空引擎"。中国南方航空股份有限公司战略规划投资部副总经理黄翔表示，展望"十五五"，南方航 空将与白云区携手共进，推动航空价值链拓展提升、供应链深度融合，助力白云谱写高质量发展新篇 章。 广东省机场管理集团有限公司副总经理邓勇刚也表示，期待和白云区一起，将独特的"临空优势"转化为 实实在在的产业优势和经济增长极，共同打造"港产城"融合发展的新生态。 作为扎根白云区18载的新 ...

2026年刚刚拉开帷幕，广州白云区的"新年第一会"绘出政企共图发展的同心圆。 以"奋进'十五五' 实现新突破"为主题的广州市白云区企业家大会1月4日在华为广州研发中心召开。大会 旨在推动企业发展战略与白云区"十五五"规划深度融合，努力构建"双赢、多赢、共赢"发展格局。 业家大会在华为广州研发中心召开，政企同心擘画高质量发展蓝图。云宣 供图 作为扎根白云区18载的新能源企业，菲利斯已从本土企业成长为国家级专精特新"小巨人"企业。展望未 来，广州菲利斯太阳能科技有限公司董事长张宝信心满满，"2026年菲利斯将在全球把本地化服务做深 做透，全力冲刺80亿元年度目标任务。""我们将巩固在高分子材料助剂领域的龙头地位，并积极探索新 材料新赛道。"作为从白云区成长起来的国家级制造业单项冠军和全区首家科创板上市企业，呈和科技 股份有限公司名誉董事长赵文林感触颇深，他期待与白云区携手，为打造百亿级新材料产业贡献力量。 "落户在白云的20年里，我们感受到了白云区对营商环境的用心打造。未来，我们将优化供应链，打 造'大健康＋农业'精品单品，进一步提升产品附加值。"广州惠鲜蔬果有限公司总经理方若鸣同样充满 信心。金铂商业则是一家扎 ...

这个看似小众的行业在2023年以来却经历了异常激烈的竞争。随着行业竞争加剧、下游需求放缓及原材 料价格波动，抗老化助剂行业进入非理性低价竞争阶段，利安隆、宿迁联盛、风光股份、鼎际得等厂家 的产品价格下跌。 以风光股份为例，其抗氧剂单剂产品在2023年毛利率为16.58%，到2024年已骤降至3.02%，2025年上半 年仅微幅回升至3.26%。 （原标题：抗氧剂行业突变！多家上市公司集体涨价，龙头企业回应：调节利润） 国产抗氧剂行业迎来密集调价潮。12月19日，鼎际得（603255.SH）在官方渠道发布关于抗氧剂产品价 格调整的说明函，宣布对公司全部抗氧剂系列产品价格进行更新，整体上调比例约为10%，新价格自发 布之日起生效。 这也是继利安隆（300596.SZ）、宿迁联盛（603065.SH）、风光股份（301100.SZ）之后，第四家抗氧 剂头部企业启动涨价，短短半个月内，抗氧剂行业已掀起集体提价潮，且调价幅度高度一致。 12月2日，利安隆率先发布调价函，拟对抗氧化剂产品上调10%左右；12月3日，宿迁联盛跟进光稳定剂 调价，幅度同样是10%左右；12月16日，行业龙头风光股份也宣布主要抗氧剂系列平均涨价 ...

这家位于广州的高分子材料助剂"龙头"，正通过收购低调布局"价值万亿"的低空赛道。 12月15日，呈和科技股份有限公司（688625.SH，以下简称"呈和科技"）在《第三届董事会第十三次会 议决议公告》中提到，董事会同意公司收购中电科翌智航（重庆）科技有限公司（以下简称"翌智航"） 48%股权。 资料显示，呈和科技成立于2002年，总部位于广州，2021年在科创板上市，是国内高分子材料助剂领域 的龙头企业。公司专注于成核剂、合成水滑石、抗氧剂等特种高分子材料助剂的研发、生产和销售。 中电科翌智航成立于2019年12月，原为中国电子科技集团控股的高科技企业，专注于无人系统指挥控 制、智能化物流运输、无人机智慧巡查等无人化、智能化领域。 收购完成后，翌智航将脱离国资属性，成为上市公司的生态企业之一。呈和科技相关负责人表示，从国 资系剥离，进入民营上市公司，是翌智航市场化转型的关键一步，有助于其加速发展规模。"双方未来 不是互为供应商、互为客户的关系，协同作用将体现在资源与技术发展的互通。" 而对于呈和科技而言，"我们还是会专注于高分子材料业务，这个是呈和坚持的核心。此次收购只是我 们往不同类型的材料、不同的应用场景 ...

低空经济的潜力正引来材料相关企业的投资布局。做高分子材料助剂的呈和科技（688625.SH）12月15 日晚公告，董事会同意收购中电科翌智航（重庆）科技有限公司（下称翌智航）48%股权，实现了在低 空经济相关领域的又一次布局。 翌智航的主业是做无人机管控平台，现已接入多家无人机企业的多款型号无人机。呈和科技投资总监段 淑丽12月16日在该公司位于广州的总部向第一财经记者说，借助翌智航的客户资源和数据积累，呈和科 技将加快低空经济相关材料的研发。 在段淑丽看来，低空经济产业新材料领域蕴藏发展机会。一类是高强度轻质材料，它可以让无人机更 轻、强度更高，从而可以增加载重量。另一类是提升电池能量密度的材料，它可以让无人机提高续航能 力。此外，热防护等材料也有市场潜力。 今年前三季度，呈和科技实现营收7.4亿元、归母净利润2.28亿元，分别同比增长14.15%和15.08%。段 淑丽说，在保持主业稳健增长的同时，呈和科技希望培育新的业务增长点。 过去五年，呈和科技通过投资基金，已间接投资了航天时代飞鹏等无人机相关企业。此次呈和科技直接 投资翌智航，段淑丽说，一是翌智航团队综合实力较强，覆盖面较广；二是借助翌智航的平台， ...

Investment Rating - The report maintains a "Strong Buy" investment rating for the company [3]. Core Views - The company has achieved a record high in quarterly profits, with revenue for the first three quarters of 2025 reaching 740 million yuan, a year-on-year increase of 14.16%, and a net profit attributable to the parent company of 228 million yuan, up 15.09% year-on-year [1][6]. - The company is actively seizing market opportunities, accelerating product innovation, and expanding its product applications downstream, which has led to a steady increase in market share and performance [6]. - The company is expected to benefit from the acceleration of domestic substitution, with its products' performance comparable to leading foreign companies [6]. Financial Data and Valuation - Revenue projections for 2025-2027 are 1.138 billion yuan, 1.388 billion yuan, and 1.721 billion yuan, respectively, with net profits of 295 million yuan, 334 million yuan, and 411 million yuan [2][6]. - The earnings per share (EPS) are projected to be 1.57 yuan, 1.77 yuan, and 2.18 yuan for the years 2025, 2026, and 2027, respectively [2][6]. - The current price-to-earnings (PE) ratios are 23.5, 20.8, and 16.9 for the years 2025, 2026, and 2027, respectively [2][6]. Company Performance - The company has maintained a market share increase in its polymer material additives, achieving double-digit growth for ten consecutive years [6]. - The company has over 180 different types of nucleating agents, synthetic talc, and composite additives in mass production, providing one-stop raw material supply capabilities to high-quality downstream customers [6]. - The company is implementing cost reduction and efficiency enhancement strategies through optimized production processes and strengthened cost control [6].

Core Insights - The company reported a revenue of 740 million RMB for Q3 2025, representing a year-on-year increase of 14%, and a net profit attributable to shareholders of 228 million RMB, up 15% year-on-year [1] - In Q3 2025, the company achieved a revenue of 269 million RMB, with a year-on-year growth of 15%, and a net profit of 81 million RMB, also up 15% year-on-year [1] - The company's main business focuses on domestic substitution and accelerated international expansion, leading to continuous growth in sales scale [1] Financial Performance - The gross profit margin for Q3 2025 was 45%, remaining stable compared to previous periods, while the expense ratio (including four expenses and taxes) was 9.7%, down 2.7 percentage points year-on-year and 1.9 percentage points quarter-on-quarter [1] - Accounts receivable for Q3 2025 stood at 410 million RMB, an increase of 110 million RMB quarter-on-quarter, indicating sustained growth in sales scale [1] Strategic Initiatives - The company is capitalizing on market opportunities to accelerate the "domestic substitution" process for high polymer material additives and is employing a differentiated competitive strategy to meet overseas customer demands, resulting in a steady increase in market share [1] - As of the first half of 2025, overseas revenue accounted for 25.39% of total revenue, indicating steady progress in the internationalization strategy [1] Global Certification and Dividend Policy - The company has obtained multiple international certifications, including EU REACH, Korea K-REACH, Turkey KKDIK, and Halal IFRC, and its Nansha plant has passed ISO9001 and ISO14001 certifications, enhancing trust among overseas customers [1] - In mid-2025, the company announced a cash dividend of 2.30 RMB (before tax) per 10 shares to all shareholders, reflecting a commitment to a stable dividend policy and reinforcing investor confidence [1] Investment Outlook - The projected net profit attributable to shareholders for 2025-2027 is estimated at 296 million RMB, 361 million RMB, and 419 million RMB respectively, maintaining a "strong buy" rating [2]

Core Insights - Chenghe Technology Co., Ltd. reported a revenue of 740 million yuan for the first three quarters of 2025, representing a year-on-year growth of 14.16% [1] - The net profit for the same period reached 228 million yuan, with a year-on-year increase of 15.09% [1] - In Q3 alone, the company achieved a record net profit of 80.54 million yuan [1] Company Performance - The company is a leading player in the domestic polymer materials additives sector, benefiting from the continuous increase in market share for its core products such as nucleating agents and synthetic hydrotalcite [1] - Recent patent authorizations in niche areas like polypropylene thin-wall injection molding and high-performance polypropylene electrical membranes have enhanced the company's product line and core competitiveness [1] International Expansion - Chenghe Technology has made significant progress in its overseas business, with a year-on-year revenue growth of 70% in the first half of the year [1] - The company has achieved breakthroughs in markets across Europe, the Middle East, and Southeast Asia [1] - The dual-driven demand from both domestic and international markets is expected to support the company's ongoing performance growth [1]

Core Viewpoint - The report outlines the ongoing supervision and assessment of Chenghe Technology Co., Ltd. by CITIC Securities, highlighting the company's financial performance, potential risks, and core competencies in the polymer materials industry. Group 1: Continuous Supervision Overview - CITIC Securities has taken over the continuous supervision responsibilities from the previous sponsor, conducting various checks and assessments as per regulatory requirements [1]. - The supervision includes reviewing corporate governance documents, financial management systems, and fundraising management practices [1]. Group 2: Financial Performance - The company's operating income for the first half of 2025 reached RMB 471.09 million, representing a 13.77% increase compared to the same period in 2024 [9]. - The net profit attributable to shareholders for the same period was RMB 31.87 million, reflecting a decrease of 21.28% due to an increase in total share capital [9]. Group 3: Major Risks - Intellectual property disputes pose a risk, as the company holds 76 patents but may face litigation or regulatory penalties related to patent infringement [2]. - Core technology leakage is a concern, with 90.94% of revenue derived from products based on proprietary technology [3]. - Product quality control is critical, as any failure in quality management could damage the company's reputation and client trust [3]. - Environmental protection and safety production risks are present due to the chemical processes involved in production, which may lead to regulatory penalties [4]. - The company's gross margin was reported at 45.79%, with potential risks of decline due to various market factors [4]. - Accounts receivable amounted to RMB 318.71 million, representing 67.65% of revenue, indicating a risk of bad debts as sales scale increases [6]. - Currency fluctuations could impact the company's foreign sales, which accounted for 25.39% of total revenue [5]. - The company faces risks related to bank acceptance bills, with RMB 96.13 million in receivables potentially at risk if the creditworthiness of the issuing parties declines [5]. - Increased market competition in the emerging fine chemical sector could affect profitability if the company fails to innovate [6]. Group 4: Core Competitiveness - Chenghe Technology is recognized as a leading enterprise in high-performance polymer materials, focusing on technological innovation and sustainable development [10]. - The company has over 300 types of nucleating agents and composite additives, providing customized solutions to meet client needs [10]. - The core products have achieved international advanced levels, with some exceeding global standards, enhancing the company's competitive edge [10]. - The company has established partnerships with universities for research and development, enhancing its innovation capabilities [12]. - Chenghe Technology has been recognized as a model enterprise for intellectual property in Guangdong Province, with a strong patent portfolio [12]. Group 5: Research and Development - R&D expenditures for the first half of 2025 totaled RMB 21.45 million, a 28.92% increase from the previous year, reflecting a commitment to product innovation [17]. - The company holds 76 valid patents, including 59 invention patents, indicating a robust focus on R&D [18]. - New projects are underway to develop advanced additives and materials, addressing specific market needs and enhancing product performance [19][20].

Core Viewpoint - Lianlong is a leading supplier of polymer material aging resistance additives, transitioning from industrial additives to health consumer products, and is recognized as a pioneer in the anti-aging sector [2][3]. Group 1: Company Overview - Lianlong is the first A-share listed company in China's polymer material industry and has developed a comprehensive range of anti-aging products, including antioxidants and light stabilizers [2]. - Lianlong Zhongwei, a subsidiary, has become a major profit contributor, generating over 1 billion yuan in sales from antioxidants and UV absorbers last year [3]. Group 2: Innovation and Market Expansion - The company is expanding its product applications from traditional industrial sectors to emerging fields such as food, pharmaceuticals, cosmetics, and new energy vehicles [3][4]. - Lianlong has established a technology center in Zhongwei to develop anti-aging products for pharmaceuticals and cosmetics, addressing new market demands [3]. Group 3: Automation and Safety - Lianlong Zhongwei has invested over 50 million yuan in automation, significantly reducing labor needs and enhancing operational safety [6][7]. - The factory employs a centralized control system for automated operations, improving safety and product quality while minimizing human intervention [6][7]. Group 4: Environmental Responsibility - Lianlong Zhongwei has implemented comprehensive environmental protection facilities, exceeding actual discharge needs, and invests 30-40 million yuan annually in waste treatment [8]. - The company emphasizes green development, aligning its safety and environmental standards with international benchmarks, and aims to enhance resource utilization and reduce emissions [8][9]. Group 5: Industry Trends - The polymer material anti-aging industry is evolving towards high-end, green, and composite products, with Lianlong focusing on technological innovation to meet domestic and international market demands [9].